Crestwood Equity Partners LP (CEQP) Financials Nov 14,
Crestwood Equity Partners LP (CEQP) Financials Nov 14, 2014, 8:01 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Crestwood Equity Partners LP
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.57B 1.79B 2.15B 2.01B 1.43B
Cost of Goods Sold (COGS) incl. D&A 1.11B 1.33B 1.69B 1.55B 1.17B
COGS excluding D&A 996.9M 1.17B 1.49B 1.38B 1B
Depreciation & Amortization Expense 115.8M 161.8M 191.8M 169.6M 167.9M
Depreciation 88.8M 126.3M 154.6M 148M 110.3M
Amortization of Intangibles 27M 35.5M 37.2M 21.6M 57.6M
Gross Income 457.9M 458.3M 468.2M 456.1M 256.5M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 279.6M 309M 323.3M 300.8M 198.1M
Research & Development - 0 0 0 0
Other SG&A 279.6M 309M 323.3M 300.8M 198.1M
Other Operating Expense 0 0 0 0 0
Unusual Expense 4.9M 0 (17.8M) 41.7M 35.5M
EBIT after Unusual Expense (4.9M) 0 17.8M (41.7M) (35.5M)
Non Operating Income/Expense (200,000) (9.5M) (59.1M) 537.7M 5.5M
Non-Operating Interest Income 0 0 0 0 100,000
Equity in Affiliates (Pretax) 0 0 0 - (100,000)
Interest Expense 69.7M 91M 113.5M 83.6M 78M
Gross Interest Expense 84.5M 97.4M 129.7M 98.4M 81.4M
Interest Capitalized 14.8M 6.4M 16.2M 14.8M 3.4M
Pretax Income 103.5M 48.8M (9.9M) 567.7M (49.6M)
Income Tax 700,000 100,000 700,000 1.8M 1M
Income Tax - Current Domestic 700,000 - 1.2M 400,000 3.8M
Income Tax - Current Foreign 0 0 0 1M -
Income Tax - Deferred Domestic 0 0 (500,000) 0 (2.8M)
Income Tax - Deferred Foreign 0 0 0 400,000 -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 102.8M 48.7M (10.6M) 565.9M (50.6M)
Minority Interest Expense 49.2M 72.5M (28.2M) 11M (57.3M)
Net Income 53.6M (23.8M) 17.6M 554.9M 6.7M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 53.6M (23.8M) 17.6M 554.9M 6.7M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 53.6M (23.8M) 17.6M 554.9M 6.7M
EPS (Basic) 1.00 (0.37) 0.17 4.44 0.06
Basic Shares Outstanding 53.71M 64.53M 105.73M 124.98M 109.15M
EPS (Diluted) 1.00 (0.37) 0.15 4.22 0.06
Diluted Shares Outstanding 53.74M 64.53M 117.68M 131.59M 113.53M
EBITDA 294.1M 311.1M 336.7M 324.9M 226.3M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...
Continue Reading
Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...
Continue Reading
Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...
Continue Reading
The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...
Continue Reading
Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...
Continue Reading
Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...
Continue Reading
Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...
Continue Reading
A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...
Continue Reading
Top 5 Most Recently Viewed Articles
Gen Z Leads the Charge in AI-Driven Loyalty The times, they are a-changin', and loyalty programs aren't immune. Hopping on the AI bandwagon, 64% of Gen Z in the UK and 55% in the US are getting more bang for their buck, utilizing AI to optimize their participation and rake in rewards. According to Comarch's latest findings, these young savants aren't just after luxury...
Continue Reading
SendCutSend Wins Gold Stevie Award at American Business Awards SendCutSend has received a significant honor by winning a coveted Gold Stevie Award in the Manufacturing category during the American Business Awards. This prestigious award program recognizes excellence in various sectors across the country. The awards attracted over 3,600 submissions from multiple...
Continue Reading
Glow Up Golden 2026 Calendar Unveiled at Pearl River Mart -Inspired by ancient Chinese timing to support modern decision-making- In a vibrant new partnership, Julie Huang, renowned writer and Chinese metaphysics practitioner, is set to launch the Glow Up Golden 2026 Calendar at Pearl River Mart. This culturally enriching calendar draws on classical Chinese wisdom, making...
Continue Reading
Investors Encouraged to Act on Luminar Technologies Lawsuit The focus is now on Luminar Technologies, Inc. (NASDAQ: LAZR) as the opportunity arises for investors to join a significant class action lawsuit. This comes in light of recent allegations of securities fraud within the company. Investors who purchased Luminar securities within the specified time frame are urged...
Continue Reading
Recent Trends in Catalyst Pharmaceuticals' Short Interest Catalyst Pharmaceuticals (CPRX) has seen a notable increase in its short percent of float, jumping by 5.8% since the last report. The latest figures indicate that about 8.17 million shares are currently sold short, representing 8.57% of all shares available for trading. Based on trading volume, it would take...
Continue Reading